ZA935943B - New formulations - Google Patents

New formulations

Info

Publication number
ZA935943B
ZA935943B ZA935943A ZA935943A ZA935943B ZA 935943 B ZA935943 B ZA 935943B ZA 935943 A ZA935943 A ZA 935943A ZA 935943 A ZA935943 A ZA 935943A ZA 935943 B ZA935943 B ZA 935943B
Authority
ZA
South Africa
Prior art keywords
new formulations
carrier
inhalation
formulations
new
Prior art date
Application number
ZA935943A
Other languages
English (en)
Inventor
Gordon Thomas Simpkin
Roy Trunley
Ann-Marie Leighton
Original Assignee
Rhone Poulenc Rorer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Ltd filed Critical Rhone Poulenc Rorer Ltd
Publication of ZA935943B publication Critical patent/ZA935943B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA935943A 1992-08-14 1993-08-13 New formulations ZA935943B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9217312A GB2269992A (en) 1992-08-14 1992-08-14 Powder inhalation formulations

Publications (1)

Publication Number Publication Date
ZA935943B true ZA935943B (en) 1994-06-09

Family

ID=10720370

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935943A ZA935943B (en) 1992-08-14 1993-08-13 New formulations

Country Status (16)

Country Link
US (1) US5908639A (de)
EP (1) EP0654991B1 (de)
JP (1) JP3787573B2 (de)
AT (1) ATE154237T1 (de)
AU (1) AU678379B2 (de)
CA (1) CA2142126C (de)
DE (1) DE69311556T2 (de)
DK (1) DK0654991T3 (de)
ES (1) ES2106362T3 (de)
GB (1) GB2269992A (de)
GR (1) GR3024468T3 (de)
IL (1) IL106665A (de)
MX (1) MX9304975A (de)
NZ (1) NZ254945A (de)
WO (1) WO1994004133A1 (de)
ZA (1) ZA935943B (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5612053A (en) 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
US6017963A (en) * 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5871010A (en) * 1996-06-10 1999-02-16 Sarnoff Corporation Inhaler apparatus with modified surfaces for enhanced release of dry powders
FR2756739B1 (fr) * 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
CA2323889A1 (en) 1997-03-12 1998-09-17 Robert W. Esmond A method for treating or preventing alzheimer's disease
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6191154B1 (en) 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US7022311B1 (en) 1999-10-12 2006-04-04 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
HU229310B1 (en) 1999-10-29 2013-10-28 Nektar Therapeutics Dry powder compositions having improved dispersivity
WO2001056581A1 (fr) * 2000-02-04 2001-08-09 Kissei Pharmaceutical Co., Ltd. Preparation en poudre pour inhalation et inhalateur de poudre contenant cette preparation
EP1941868A3 (de) 2000-02-28 2011-06-29 PharmaKodex Limited Verbesserungen an oder im Zusammenhang mit der Verabreichung von oralen Arzneien
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CN100551358C (zh) 2000-06-27 2009-10-21 维克多瑞有限公司 用于药物组合物的颗粒的制备方法
DE60131399T3 (de) * 2000-06-27 2019-11-14 Vectura Ltd. Herstellungsverfahren für partikel zur verwendung in einer arzneizusammensetzung
ATE446085T1 (de) * 2000-11-30 2009-11-15 Vectura Ltd Partikel zur verwendung in einer pharmazeutischen zusammensetzung
DK1337240T4 (en) 2000-11-30 2015-01-05 Vectura Ltd A process for the preparation of particles for use in a pharmaceutical composition
WO2003020197A1 (en) 2001-09-05 2003-03-13 Vectura Limited Improvements in or relating to the delivery of oral drugs
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
WO2003074029A1 (en) 2002-03-07 2003-09-12 Vectura Limited Fast melt multiparticulate formulations for oral delivery
DE60318938T2 (de) 2002-03-20 2009-01-22 Mannkind Corp., Valencia Inhalationsgerät
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
CN1758930B (zh) 2003-03-27 2010-06-09 株式会社新日本科学 鼻腔用粉末药剂喷药装置
ITMI20040795A1 (it) * 2004-04-23 2004-07-23 Eratech S R L Composizione farmaceutica solida secca suo processo di preparazione e sospensione acquosa stabile ottenuta dalla stessa
EP1785145A4 (de) 2004-08-10 2008-08-13 Translational Res Ltd Transnasale zusammensetzung mit sofortiger wirkung und hoher resorbierbarkeit
EP1786784B1 (de) 2004-08-20 2010-10-27 MannKind Corporation Katalyse der diketopiperazinsynthese
CA2578175C (en) 2004-08-23 2014-10-14 Mannkind Corporation Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery
EP1657278A1 (de) 2004-11-12 2006-05-17 SOLVAY (Société Anonyme) Beschichtete Calciumcarbonat-Teilchen mit grosser spezifischer Oberfläche
US7803404B2 (en) 2005-09-14 2010-09-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
US20070172430A1 (en) * 2006-01-20 2007-07-26 Nastech Pharmaceutical Company Inc. Dry powder compositions for rna influenza therapeutics
BRPI0707991B8 (pt) 2006-02-22 2021-05-25 Mannkind Corp métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco
EP2116264B1 (de) 2006-12-26 2017-09-27 Shin Nippon Biomedical Laboratories, Ltd. Zubereitung zur transnasalen anwendung
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
EP2570147B1 (de) 2008-06-13 2017-10-18 MannKind Corporation Trockenpulverinhalator und System zur Wirkstofffreisetzung
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
BRPI0915803A2 (pt) * 2008-07-18 2015-11-10 Prosonix Ltd processo para aumentar a cristalinidade de pelo menos um material sólido, partícula, composição farmacêutica, e, inalador
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP3578169B1 (de) 2009-02-26 2024-06-26 Glaxo Group Limited Pharmazeutische formulierungen enthaltend 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
PL2405963T3 (pl) 2009-03-11 2014-04-30 Mannkind Corp Urządzenie, układ i sposób pomiaru oporu inhalatora
WO2010131486A1 (en) 2009-05-15 2010-11-18 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
KR20180079458A (ko) 2009-06-12 2018-07-10 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
WO2011013003A2 (en) 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
EP2496295A1 (de) 2009-11-03 2012-09-12 MannKind Corporation Vorrichtung und verfahren zur simulation von einatmungsanstrengungen
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
CN105667994B (zh) 2011-04-01 2018-04-06 曼金德公司 用于药物药盒的泡罩包装
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
CN108057154B (zh) 2012-07-12 2021-04-16 曼金德公司 干粉药物输送***和方法
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
CA2906817C (en) 2013-03-15 2022-01-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
JP2016530930A (ja) 2013-08-05 2016-10-06 マンカインド コーポレイション 通気装置及び方法
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US4916230A (en) * 1984-07-02 1990-04-10 Merck & Co., Inc. Process for preparing novel N-(acyloxy-alkoxy)carbonyl derivatives useful as bioreversible prodrug moieties for primary and secondary amine functions in drugs
DE3872635T2 (de) * 1987-04-09 1992-12-17 Fisons Plc Pentamidin enthaltende pharmazeutische zusammensetzungen.
US5039699A (en) * 1989-03-27 1991-08-13 Lederle (Japan), Ltd. Anti-peptic ulcer agent
JPH05963A (ja) * 1990-04-13 1993-01-08 Toray Ind Inc ポリペプチド類組成物
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
IE71647B1 (en) * 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives

Also Published As

Publication number Publication date
EP0654991A1 (de) 1995-05-31
GR3024468T3 (en) 1997-11-28
AU678379B2 (en) 1997-05-29
DE69311556D1 (de) 1997-07-17
WO1994004133A1 (en) 1994-03-03
DK0654991T3 (da) 1997-12-29
CA2142126A1 (en) 1994-03-03
IL106665A (en) 1998-02-22
ES2106362T3 (es) 1997-11-01
DE69311556T2 (de) 1997-12-04
JPH08500109A (ja) 1996-01-09
JP3787573B2 (ja) 2006-06-21
ATE154237T1 (de) 1997-06-15
MX9304975A (es) 1994-05-31
IL106665A0 (en) 1993-12-08
AU4725693A (en) 1994-03-15
GB9217312D0 (en) 1992-09-30
NZ254945A (en) 1996-06-25
CA2142126C (en) 2007-01-09
GB2269992A (en) 1994-03-02
US5908639A (en) 1999-06-01
EP0654991B1 (de) 1997-06-11

Similar Documents

Publication Publication Date Title
ZA935943B (en) New formulations
TW286273B (de)
EP0647133A4 (de) Zusammensetzungen und verfahren zur verbesserte arzneimittelabgabe.
HUT76900A (en) Dry powder inhalator medicament carrier
MY131774A (en) Coated pesticidal agents, processes for their preparation and compositions containing them
NZ238739A (en) Aerosol formulations comprising a powdered drug, a hydrofluorocarbon propellant and a perfluoroalkylsulphonamidoalkylphosphate surface-active agent
EP0995434A3 (de) Medizinische Aerosolformulierungen
CZ20011581A3 (cs) Systém pro podávání bioaktivní sloučeniny inhalací
MXPA97002401A (es) Agente antiinflamatorio para uso externo.
CA2277824A1 (en) Dosage composition for nasal delivery and method of use of the same
AU8370491A (en) Antimicrobial peptides and an antimicrobial agent
IL111533A0 (en) Quinoxalinedione derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
HU904007D0 (en) Medical preparations providing regulated active agent discharge and processes for the preparation thereof
IL97931A0 (en) Pyridazine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AU631334B2 (en) 2-substituted n,n'-ditrimethoxybenzoyl piperazines, and therapeutic compositions containing them
AU2721995A (en) Coated pesticidal agents, processing for their preparation and compositions containing them
AU7467994A (en) Novel polysaccharide and radioprotective agent containing the same as active ingredient
GB9312982D0 (en) Active agent delivery systems
AU1092095A (en) Intra-uterine ring for the release of an active agent, such as a hormone, and an introducer
HUT75711A (en) The use of dimeticone as a transport and carrier system and/or drug delivery system, and pharmaceutical compositions containing dimeticone
HUT67313A (en) Process for prepg. new bacis ethers and pharmaceutical compn.s containing them
GB9315411D0 (en) Active agent delivery
BG101119A (en) Analgesic composition
IL94658A0 (en) 1,5-diazabicyclodiones and pharmaceutical compositions containing them
PL283584A1 (en) Dispersing agent for powdered polymers